These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 15885355)
21. Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers. Kurihara T; Ikeda S; Ishizaki Y; Fujimori M; Tokumoto N; Hirata Y; Ozaki S; Okajima M; Sugino K; Asahara T Thyroid; 2004 Dec; 14(12):1020-9. PubMed ID: 15650354 [TBL] [Abstract][Full Text] [Related]
22. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842 [TBL] [Abstract][Full Text] [Related]
23. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Barandon L; Dufourcq P; Costet P; Moreau C; Allières C; Daret D; Dos Santos P; Daniel Lamazière JM; Couffinhal T; Duplàa C Circ Res; 2005 Jun; 96(12):1299-306. PubMed ID: 15920021 [TBL] [Abstract][Full Text] [Related]
24. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. Topol L; Jiang X; Choi H; Garrett-Beal L; Carolan PJ; Yang Y J Cell Biol; 2003 Sep; 162(5):899-908. PubMed ID: 12952940 [TBL] [Abstract][Full Text] [Related]
25. Implication of galectin-3 in Wnt signaling. Shimura T; Takenaka Y; Fukumori T; Tsutsumi S; Okada K; Hogan V; Kikuchi A; Kuwano H; Raz A Cancer Res; 2005 May; 65(9):3535-7. PubMed ID: 15867344 [TBL] [Abstract][Full Text] [Related]
26. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]
27. Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Naito AT; Akazawa H; Takano H; Minamino T; Nagai T; Aburatani H; Komuro I Circ Res; 2005 Jul; 97(2):144-51. PubMed ID: 15994435 [TBL] [Abstract][Full Text] [Related]
28. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853 [TBL] [Abstract][Full Text] [Related]
29. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090 [TBL] [Abstract][Full Text] [Related]
30. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells. Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998 [TBL] [Abstract][Full Text] [Related]
31. Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells. Kenny PA; Enver T; Ashworth A BMC Cancer; 2005 Jan; 5():3. PubMed ID: 15642117 [TBL] [Abstract][Full Text] [Related]
32. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein. Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679 [TBL] [Abstract][Full Text] [Related]
33. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling. Lin-Marq N; Borel C; Antonarakis SE Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909 [TBL] [Abstract][Full Text] [Related]
34. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells. Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395 [TBL] [Abstract][Full Text] [Related]
35. Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis. Farago M; Dominguez I; Landesman-Bollag E; Xu X; Rosner A; Cardiff RD; Seldin DC Cancer Res; 2005 Jul; 65(13):5792-801. PubMed ID: 15994955 [TBL] [Abstract][Full Text] [Related]
39. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer]. Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870 [TBL] [Abstract][Full Text] [Related]
40. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]